Pharmaceuticals in Germany

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $350	39 Pages	MarketLine	September, 2024	MTLN19382321

Best Price Guarantee
Price	from $350
Length	39 Pages
Publisher	MarketLine
Published Date	September, 2024
SKU	MTLN19382321

Pharmaceuticals in Germany

Summary

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The German pharmaceuticals market registered revenues of $87.2 billion in 2023, representing a compound annual growth rate (CAGR) of 5.2% between 2018 and 2023.
Germany captured the largest share of the European pharmaceuticals market in 2023, accounting for a share of 23.5%.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Germany
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Germany pharmaceuticals market by value in 2023?
What will be the size of the Germany pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Germany pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Germany's pharmaceuticals market?

1 Executive Summary: 1.1. Market value; 1.2. Market value forecast; 1.3. Geography segmentation; 1.4. Market rivalry; 1.5. Competitive landscape
2 Market Overview: 2.1. Market definition; 2.2. Market analysis
3 Market Data: 3.1. Market value
4 Market Segmentation: 4.1. Geography segmentation
5 Market Outlook: 5.1. Market value forecast
6 Five Forces Analysis: 6.1. Summary; 6.2. Buyer power; 6.3. Supplier power; 6.4. New entrants; 6.5. Threat of substitutes; 6.6. Degree of rivalry
7 Competitive Landscape: 7.1. Who are the leading players?; 7.2. What are the strengths of the leading players?; 7.3. What are the strategies of the leading players?; 7.4. What are the recent developments in the market?
8 Company Profiles: 8.1. Bayer AG; 8.2. Boehringer Ingelheim GmbH; 8.3. F. Hoffmann-La Roche Ltd
9 Macroeconomic Indicators: 9.1. Country data
10 Appendix: 10.1. Methodology; 10.2. Industry associations; 10.3. Related MarketLine research; 10.4. About MarketLine
List of Tables: Table 1: Germany pharmaceuticals market value: $ billion, 2018-23; Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2023; Table 3: Germany pharmaceuticals market value forecast: $ billion, 2023-28; Table 4: Bayer AG: Key Facts; Table 5: Bayer AG: Annual Financial Ratios; Table 6: Bayer AG: Key Employees; Table 7: Bayer AG: Key Employees Continued; Table 8: Boehringer Ingelheim GmbH: Key Facts; Table 9: Boehringer Ingelheim GmbH: Key Employees; Table 10: F. Hoffmann-La Roche Ltd: Key Facts; Table 11: F. Hoffmann-La Roche Ltd: Key Employees; Table 12: Germany Size of Population (million), 2019-23; Table 13: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 14: Germany GDP (Current Prices, $ Billion), 2019-23; Table 15: Germany Inflation, 2019-23; Table 16: Germany Consumer Price Index (Absolute), 2019-23; Table 17: Germany exchange rate, 2018-23
List of Figures: Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024); Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024); Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)